跳至主要内容
临床试验/EUCTR2012-000054-63-ES
EUCTR2012-000054-63-ES进行中(未招募)1 期

Salvage therapy with chemotherapy and Natural Killer cells in relapsed/refractory paediatric T cell lymphoblastic leukaemia and lymphoma. - NK cells in leukemia / lymphoma

FUNDACION INVESTIGACION BIOMEDICA HOSPITAL NINO JESUS0 个研究点开始时间: 2012年1月27日最近更新:

试验速览

阶段
1 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. Patients betweem 0 and 21 years of age with diagnosis of acute lymphoblastic T leukemia or lymphoma, relapsed or refractary.
  • 2. Lansky index > 60%
  • 3. Left ventricular ejection fraction > 39%
  • 4. Negative HIV serology
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 6
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 4
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1. Patients with history of bad therapeutical compliance
  • 2. Patients not valid after psycho-social evaluation
  • 3. Severe (4) functional organ disorders (hepatic, renal, respiratory) according to NCI CTCAE v4 criteria
  • 4. Should be considered the contraindications, drug interactions, precautions for use and dose reductions indicated in the corresponding Summary of Product Characteristics (SmPC) (read the SmPC)

研究者

发起方
FUNDACION INVESTIGACION BIOMEDICA HOSPITAL NINO JESUS

相似试验